Biotech Food Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Apr
9
2020
COVID-19 Unsympathetic to TSCA Compliance Keller and Heckman LLP
Apr
9
2020
“Method of Preparation” Claims Found Patent-Eligible Under §101 McDermott Will & Emery
Apr
9
2020
United States Intervenes and Settles Qui Tam False Claims Act Case Against Compound Pharmacies for $426,000 Kohn, Kohn & Colapinto
Apr
9
2020
Update: Key FDA Actions for COVID-19 Devices and Therapies Sheppard, Mullin, Richter & Hampton LLP
Apr
8
2020
National Academies Publish Quadrennial Review of NNI Bergeson & Campbell, P.C.
Apr
8
2020
DOT Issues COVID-19 Enforcement Discretion for Cylinder Requalification Requirements Keller and Heckman LLP
Apr
8
2020
La Croix Loses Rule 11 Battle but Wins War, as Plaintiff Retracts Lawsuit Allegations Proskauer Rose LLP
Apr
8
2020
COVID-19 Update: When Computers Invent: How the Use of Artificial Intelligence to Treat COVID-19 Highlights Novel Inventorship Issues Cadwalader, Wickersham & Taft LLP
Apr
8
2020
Making Sense of FDA’s Recent Guidances on Personal Protective Equipment (PPE) Womble Bond Dickinson (US) LLP
Apr
8
2020
USDA Decides to Initiate COOL Rulemaking to Clear Consumer Confusion Keller and Heckman LLP
Apr
8
2020
If Successful, Teva Suit Could Decrease Generic Competition ArentFox Schiff LLP
Apr
7
2020
Personalized Medicine Coalition Releases Spring 2020 Newsletter Amid COVID-19 Foley & Lardner LLP
Apr
7
2020
Nota Bene Episode 73: “Quarantine and Chill”: Will COVID-19 Impact the Cannabis Industry? with Whitney Hodges Sheppard, Mullin, Richter & Hampton LLP
Apr
7
2020
Supreme Court Will Address Personal Jurisdiction After States Courts Interpret BMS Decision ArentFox Schiff LLP
Apr
7
2020
FDA Temporarily Relaxes Policies Relating to Eggs Produced for and Sold in the Retail Market Keller and Heckman LLP
Apr
6
2020
CARES Act Prompts Changes to Employer-Sponsored Health Plans Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
6
2020
U.S. Department of Justice Issues First COVID-19-Related Business Review Letter to Medical Supplies Distributors Mintz
Apr
6
2020
CMS “Hospitals Without Walls” Waiver: Looking To ASCs to Provide Relief Sheppard, Mullin, Richter & Hampton LLP
Apr
6
2020
Push Back on Plastic Bag Bans Keller and Heckman LLP
Apr
6
2020
Novel Virus Brings Novel Coverage Theories ArentFox Schiff LLP
Apr
6
2020
COVID-19 Liability Immunity - What You Need to Know Now Womble Bond Dickinson (US) LLP
Apr
6
2020
EPA Takes Action to Ease the Production of Disinfectants Approved for Use Against the Novel Coronavirus Beveridge & Diamond PC
Apr
6
2020
FDA Policy Provides Enforcement Relief Regarding Certain Medical Devices Due to Pandemic Beveridge & Diamond PC
Apr
6
2020
EPA Highlights Enforcement Against Disinfectant Products Making Fraudulent Coronavirus Claims Beveridge & Diamond PC
Apr
6
2020
FDA Resumes Records Review Under the FSVP Rule by Remote Inspections Instead of Onsite Visits to Importers Keller and Heckman LLP
Apr
3
2020
COVID-19: Notable Impacts for Post-Acute Providers from the CARES Act, CMS Blanket Waivers, and the CMS Interim Final Rule Foley & Lardner LLP
Apr
3
2020
Commercial Payors and Medicaid Telehealth Billing Womble Bond Dickinson (US) LLP
Apr
3
2020
FDA Funding Opportunity Announcement: “Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional” Faegre Drinker
Apr
3
2020
Legal Liability of Healthcare Providers for Care Provided During COVID-19 Pandemic Epstein Becker & Green, P.C.
Apr
3
2020
Russian Federation Accepting Nominations to New Chemical Inventory Bergeson & Campbell, P.C.
Apr
2
2020
CMS Issues Temporary Waivers in Broad Coronavirus Response Sheppard, Mullin, Richter & Hampton LLP
Apr
2
2020
Class Action Ascertainability in the Eleventh Circuit: What Makes the Cut? Bilzin Sumberg
Apr
2
2020
Doctor Fraud: False Claims and Controlled Substances an Ongoing Problem for the Medical Industry Stark & Stark
Apr
2
2020
Strategies for Collaborating With Other Health Care Firms to Expand Production and Secure the Supply Chain Bracewell LLP
Apr
2
2020
FDA Provides Temporary Flexibility to Chain Restaurants and Similar Retail Food Establishments in Response to COVID-19 Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins